Kidney xenotransplantation

Kidney International

Volumn 85, Issue 2, 2014, Pages 265-275

  Cowan, Peter J ^a,b   Cooper, David K C ^c   D'apice, Anthony J F ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

genetically modified; immunosuppression; pig to primate model; tolerance; transgenesis; xenotransplantation

Indexed keywords

ALEMTUZUMAB; ALPHA 1,3 GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN G; RITUXIMAB; THROMBOMODULIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADAPTIVE IMMUNITY; ANTIBODY TITER; ANTIGEN PRESENTATION; CARBOHYDRATE SYNTHESIS; DISEASE CONTROL; DNA MODIFICATION; DOWN REGULATION; GLYCOSYLATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOBIOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOREGULATION; INFECTION RISK; INNATE IMMUNITY; KIDNEY TRANSPLANTATION; MOLECULAR GENETICS; NONHUMAN; ORGAN DONOR; PRIMATE; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SWINE; T LYMPHOCYTE; THEORETICAL MODEL; UPREGULATION; XENOGRAFT; XENOTRANSPLANTATION;

ADAPTIVE IMMUNITY; ANIMALS; ANIMALS, GENETICALLY MODIFIED; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, INNATE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; PHENOTYPE; SPECIES SPECIFICITY; SWINE; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 84895907263     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.381     Document Type: Review

References (163)

1. Pondrom S. The AJT Report: News and issues that affect organ and tissue transplantation. Am J Transplant 2012; 12: 2565-2566
2. Cooper. DKC. A brief history of cross-species organ transplantation. Proc (Bayl Univ Med Cent) 2012; 25: 49-57
3. Bengtsson A, Svalander CT, Molne J et al. Extracorporeal (ex vivo') connection of pig kidneys to humans. III. Studies of plasma complement activation and complement deposition in the kidney tissue. Xenotransplantation 1998; 5: 176-183
4. Ekser B, Ezzelarab M, Hara H et al. Clinical xenotransplantation: The next medical revolution? Lancet 2012; 379: 672-683
5. Yamada K, Yazawa K, Shimizu A et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005; 11: 32-34
6. Cozzi E, Bhatti F, Schmoeckel M et al. Long-Term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000; 70: 15-21
7. Griesemer AD, Hirakata A, Shimizu A et al. Results of gal-knockout porcine thymokidney xenografts. Am J Transplant 2009; 9: 2669-2678
8. Baldan N, Rigotti P, Calabrese F et al. Ureteral stenosis in HDAF pig-To-primate renal xenotransplantation: A phenomenon related to immunological events? Am J Transplant 2004; 4: 475-481
9. Gollackner B, Knosalla C, Houser S et al. Pig kidney transplantation in baboons treated intravenously with a bovine serum albumin-Galalpha1-3Gal conjugate. Xenotransplantation 2003; 10: 606-614
10. Chen G, Qian H, Starzl T et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005; 11: 1295-1298
11. Chen G, Sun H, Yang H et al. The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Transplantation 2006; 81: 273-283
12. Ibrahim Z, Busch J, Awwad M et al. Selected physiologic compatibilities and incompatibilities between human and porcine organ systems. Xenotransplantation 2006; 13: 488-499
13. Soin B, Smith KG, Zaidi A et al. Physiological aspects of pig-To-primate renal xenotransplantation. Kidney Int 2001; 60: 1592-1597
14. Galili U, Shohet SB, Kobrin E et al. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 1988; 263: 17755-17762
15. Macher BA, Galili U. The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: A carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta 2008; 1780: 75-88
16. Spiezia L, Bertini D, Boldrin M et al. Reference values for thromboelastometry (ROTEM(R)) in cynomolgus monkeys (Macaca fascicularis). Thromb Res 2010; 126: E294-e297
17. Miwa Y, Kobayashi T, Nagasaka T et al. Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-To-human xenotransplantation? Xenotransplantation 2004; 11: 247-253
18. Taylor RE, Gregg CJ, Padler-Karavani V et al. Novel mechanism for the generation of human xeno-Autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid. J Exp Med 2010; 207: 1637-1646
19. Larsen RD, Rivera-Marrero CA, Ernst LK et al. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-D-Gal(1,4)-D-GlcNAc alpha(1,3)-galactosyltransferase cDNA. J Biol Chem 1990; 265: 7055-7061
20. Varki A, Gagneux P. Multifarious roles of sialic acids in immunity. Ann NY Acad Sci 2012; 1253: 16-36
21. Galili U, Mandrell RE, Hamadeh RM et al. Interaction between human natural anti-Alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 1988; 56: 1730-1737
22. Parker W, Bruno D, Holzknecht ZE et al. Characterization and affinity isolation of xenoreactive human natural antibodies. J Immunol 1994; 153: 3791-3803
23. Galili U, Rachmilewitz EA, Peleg A et al. A unique natural human IgG antibody with anti-Alpha-galactosyl specificity. J Exp Med 1984; 160: 1519-1531
24. Shimizu A, Yamada K. Pathology of renal xenograft rejection in pig to non-human primate transplantation. Clin Transplant 2006; 20(Suppl 15): 46-52
25. Cowan PJ, Aminian A, Barlow H et al. Renal xenografts from tripletransgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 2000; 69: 2504-2515
26. Xu Y, Lorf T, Sablinski T et al. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column. Transplantation 1998; 65: 172-179
27. Cowan PJ, Salvaris EJ, Crikis S et al. Gal KO pig renal xenografts are not hyperacutely rejected by non-immunosuppressed baboons. Am J Transplant 2006; 6: 1050
28. Saethre M, Baumann BC, Fung M et al. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells. Transplantation 2007; 84: 244-250
29. Baumann BC, Stussi G, Huggel K et al. Reactivity of human natural antibodies to endothelial cells from Galalpha(1,3)Gal-deficient pigs. Transplantation 2007; 83: 193-201
30. Cowan PJ, Roussel JC, d'Apice AJ. The vascular and coagulation issues in xenotransplantation. Curr Opin Organ Transplant 2009; 14: 161-167
31. Artrip JH, Kwiatkowski P, Michler RE et al. Target cell susceptibility to lysis by human natural killer cells is augmented by alpha(1,3)- galactosyltransferase and reduced by alpha(1, 2)-fucosyltransferase. J Biol Chem 1999; 274: 10717-10722
32. Jin R, Greenwald A, Peterson MD et al. Human monocytes recognize porcine endothelium via the interaction of galectin 3 and alpha-GAL. J Immunol 2006; 177: 1289-1295
33. Matter-Reissmann UB, Forte P, Schneider MK et al. Xenogeneic human NK cytotoxicity against porcine endothelial cells is perforin/granzyme B dependent and not inhibited by Bcl-2 overexpression. Xenotransplantation 2002; 9: 325-337
34. Li S, Waer M, Billiau AD. Xenotransplantation: Role of natural immunity. Transpl Immunol. 2009; 21: 70-74
35. Sullivan JA, Oettinger HF, Sachs DH et al. Analysis of polymorphism in porcine MHC class I genes: Alterations in signals recognized by human cytotoxic lymphocytes. J Immunol 1997; 159: 2318-2326
36. Subramanian S, Parthasarathy R, Sen S et al. Species-And cell typespecific interactions between CD47 and human SIRPalpha. Blood 2006; 107: 2548-2556
37. Ide K, Wang H, Tahara H et al. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci USA 2007; 104: 5062-5066
38. Cowan PJ, Robson SC, d'Apice AJ. Controlling coagulation dysregulation in xenotransplantation. Curr Opin Organ Transplant 2011; 16: 214-221
39. Shimizu A, Yamada K, Yamamoto S et al. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-Transgenic swineto-baboon kidney xenografts. J Am Soc Nephrol 2005; 16: 2732-2745
40. Shimizu A, Yamada K, Robson SC et al. Pathologic characteristics of transplanted kidney xenografts. J Am Soc Nephrol 2012; 23: 225-235
41. Houser SL, Kuwaki K, Knosalla C et al. Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 2004; 11: 416-425
42. Ezzelarab M, Garcia B, Azimzadeh A et al. The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation 2009; 87: 805-812
43. Ierino FL, Kozlowski T, Siegel JB et al. Disseminated intravascular coagulation in association with the delayed rejection of pig-To-baboon renal xenografts. Transplantation 1998; 66: 1439-1450
44. Buhler L, Basker M, Alwayn IP et al. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 2000; 70: 1323-1331
45. Cozzi E, Simioni P, Boldrin M et al. Alterations in the coagulation profile in renal pig-To-monkey xenotransplantation. Am J Transplant 2004; 4: 335-345
46. Lin CC, Ezzelarab M, Shapiro R et al. Recipient tissue factor expression is associated with consumptive coagulopathy in pig-To-primate kidney xenotransplantation. Am J Transplant 2010; 10: 1556-1568
47. Saadi S, Platt JL. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 1995; 181: 21-31
48. Palmetshofer A, Robson SC, Bach FH. Tyrosine phosphorylation following lectin mediated endothelial cell stimulation. Xenotransplantation 1998; 5: 61-66
49. Palmetshofer A, Galili U, Dalmasso AP et al. Alpha-galactosyl epitopemediated activation of porcine aortic endothelial cells: Type II activation. Transplantation 1998; 65: 971-978
50. Gollackner B, Goh SK, Qawi I et al. Acute vascular rejection of xenografts: Roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation 2004; 77: 1735-1741
51. Lin CC, Chen D, McVey JH et al. Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells. Transplantation 2008; 86: 702-709
52. Osterud B, Olsen JO. Human platelets do not express tissue factor. Thromb Res 2013; 132: 112-115
53. Ghanekar A, Mendicino M, Liu H et al. Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection. J Immunol 2004; 172: 5693-5701
54. Miwa Y, Yamamoto K, Onishi A et al. Potential value of human thrombomodulin and DAF expression for coagulation control in pig-Tohuman xenotransplantation. Xenotransplantation 2010; 17: 26-37
55. Esmon CT, Esmon NL. The link between vascular features and thrombosis. Annu Rev Physiol 2011; 73: 503-514
56. Bae JS, Yang L, Rezaie AR. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc Natl Acad Sci USA 2007; 104: 2867-2872
57. Roussel JC, Moran CJ, Salvaris EJ et al. Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI. Am J Transplant 2008; 8: 1101-1112
58. Siegel JB, Grey ST, Lesnikoski BA et al. Xenogeneic endothelial cells activate human prothrombin. Transplantation 1997; 64: 888-896
59. Lawson JH, Daniels LJ, Platt JL. The evaluation of thrombomodulin activity in porcine to human xenotransplantation. Transplant Proc 1997; 29: 884-885
60. Mazzucato M, De Marco L, Pradella P et al. Porcine von Willebrand factor binding to human platelet GPIb induces transmembrane calcium influx. Thromb Haemost 1996; 75: 655-660
61. Schulte am Esch J 2nd, Cruz MA, Siegel JB et al. Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor. Blood 1997; 90: 4425-4437
62. Schulte Am Esch J 2nd, Robson SC, Knoefel WT et al. O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors. Xenotransplantation 2005; 12: 30-37
63. Scalea J, Hanecamp I, Robson SC et al. T-cell-mediated immunological barriers to xenotransplantation. Xenotransplantation 2012; 19: 23-30
64. Yamada K, Sachs DH, DerSimonian H. Direct and indirect recognition of pig class II antigens by human T cells. Transplant Proc 1995; 27: 258-259
65. Galili U. Induced anti-non gal antibodies in human xenograft recipients. Transplantation 2012; 93: 11-16
66. Platt JL, Lin SS, McGregor CG. Acute vascular rejection. Xenotransplantation 1998; 5: 169-175
67. Dorling A. Are anti-endothelial cell antibodies a pre-requisite for the acute vascular rejection of xenografts? Xenotransplantation 2003; 10: 16-23
68. Bach FH, Winkler H, Ferran C et al. Delayed xenograft rejection. Immunol Today. 1996; 17: 379-384
69. Shimizu A, Yamada K. Histopathology of xenografts in pig to nonhuman primate discordant xenotransplantation. Clin Transplant 2010; 24(Suppl 22): 11-15
70. Tseng YL, Moran K, Dor FJ et al. Elicited antibodies in baboons exposed to tissues from alpha1,3-galactosyltransferase gene-knockout pigs. Transplantation 2006; 81: 1058-1062
71. Lam TT, Paniagua R, Shivaram G et al. Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-Transgenic porcine hearts in cynomolgus monkeys. Xenotransplantation 2004; 11: 531-535
72. Breimer ME. Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era. Xenotransplantation 2011; 18: 215-228
73. Miyagawa S, Ueno T, Nagashima H et al. Carbohydrate antigens. Curr Opin Organ Transplant 2012; 17: 174-179
74. Yeh P, Ezzelarab M, Bovin N et al. Investigation of potential carbohydrate antigen targets for human and baboon antibodies. Xenotransplantation 2010; 17: 197-206
75. Byrne GW, Stalboerger PG, Davila E et al. Proteomic identification of non-Gal antibody targets after pig-To-primate cardiac xenotransplantation. Xenotransplantation 2008; 15: 268-276
76. Burlak C, Wang ZY, Chihara RK et al. Identification of human preformed antibody targets in GTKO pigs. Xenotransplantation 2012; 19: 92-101
77. Byrne GW, Stalboerger PG, Du Z et al. Identification of new carbohydrate and membrane protein antigens in cardiac xenotransplantation. Transplantation 2011; 91: 287-292
78. Fodor WL, Williams BL, Matis LA et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci USA 1994; 91: 11153-11157
79. Cozzi E, Langford GA, Richards A et al. Expression of human decay accelerating factor in transgenic pigs. Transplant Proc 1994; 26: 1402-1403
80. McCurry KR, Kooyman DL, Alvarado CG et al. Human complement regulatory proteins protect swine-To-primate cardiac xenografts from humoral injury. Nat Med 1995; 1: 423-427
81. Sachs DH, Galli C. Genetic manipulation in pigs. Curr Opin Organ Transplant 2009; 14: 148-153
82. Hauschild J, Petersen B, Santiago Y et al. Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci USA. 2011; 108: 12013-12017
83. Carlson DF, Tan W, Lillico SG et al. Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci USA 2012; 109: 17382-17387
84. Fisicaro N, Londrigan SL, Brady JL et al. Versatile co-expression of graft-protective proteins using 2A-linked cassettes. Xenotransplantation 2011; 18: 121-130
85. Sharma A, Okabe J, Birch P et al. Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase. Proc Natl Acad Sci USA 1996; 93: 7190-7195
86. Miyagawa S, Murakami H, Takahagi Y et al. Remodeling of the major pig xenoantigen by N-Acetylglucosaminyltransferase III in transgenic pig. J Biol Chem 2001; 276: 39310-39319
87. Dai Y, Vaught TD, Boone J et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002; 20: 251-255
88. Lai L, Kolber-Simonds D, Park KW et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089-1092
89. Phelps CJ, Koike C, Vaught TD et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299: 411-414
90. Kolber-Simonds D, Lai L, Watt SR et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 2004; 101: 7335-7340
91. Nottle MB, Beebe LF, Harrison SJ et al. Production of homozygous alpha-1,3-galactosyltransferase knockout pigs by breeding and somatic cell nuclear transfer. Xenotransplantation 2007; 14: 339-344
92. Fujimura T, Takahagi Y, Shigehisa T et al. Production of alpha 1,3-galactosyltransferase gene-deficient pigs by somatic cell nuclear transfer: A novel selection method for gal alpha 1,3-Gal antigen-deficient cells. Mol Reprod Dev 2008; 75: 1372-1378
93. McGregor CG, Ricci D, Miyagi N et al. Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts. Transplantation 2012; 93: 686-692
94. Lutz AJ, Li P, Estrada JL et al. Double knockout pigs deficient in N-glycolylneuraminic acid and Galactose alpha-1,3-Galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation 2013; 20: 27-35
95. Cowan PJ, d'Apice AJ. Complement activation and coagulation in xenotransplantation. Immunol Cell Biol 2009; 87: 203-208
96. Morgan BP, Berg CW, Harris CL. Homologous restriction'' in complement lysis: Roles of membrane complement regulators. Xenotransplantation 2005; 12: 258-265
97. Fisicaro N, Aminian A, Hinchliffe SJ et al. The pig analogue of CD59 protects transgenic mouse hearts from injury by human complement. Transplantation 2000; 70: 963-968
98. Cowan PJ, Aminian A, Barlow H et al. Protective effects of recombinant human antithrombin III in pig-To-primate renal xenotransplantation. Am J Transplant 2002; 2: 520-525
99. Loveland BE, Milland J, Kyriakou P et al. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Xenotransplantation 2004; 11: 171-183
100. Menoret S, Plat M, Blancho G et al. Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-Tobaboon combination. Transplantation 2004; 77: 1468-1471
101. Platt JL, Vercellotti GM, Lindman BJ et al. Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J Exp Med 1990; 171: 1363-1368
102. Menschikowski M, Hagelgans A, Eisenhofer G et al. Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathways. Exp Cell Res 2009; 315: 2673-2682
103. Robson SC, Kaczmarek E, Siegel JB et al. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 1997; 185: 153-163
104. Chen D, Weber M, McVey JH et al. Complete inhibition of acute humoral rejection using regulated expression of membrane-Tethered anticoagulants on xenograft endothelium. Am J Transplant 2004; 4: 1958-1963
105. Crikis S, Zhang XM, Dezfouli S et al. Anti-inflammatory and anticoagulant effects of transgenic expression of human thrombomodulin in mice. Am J Transplant 2010; 10: 242-250
106. Petersen B, Ramackers W, Tiede A et al. Pigs transgenic for human thrombomodulin have elevated production of activated protein C. Xenotransplantation 2009; 16: 486-495
107. Yazaki S, Iwamoto M, Onishi A et al. Production of cloned pigs expressing human thrombomodulin in endothelial cells. Xenotransplantation 2012; 19: 82-91
108. Lee HJ, Lee BC, Kim YH et al. Characterization of transgenic pigs that express human decay accelerating factor and cell membrane-Tethered human tissue factor pathway inhibitor. Reprod Domest Anim 2011; 46: 325-332
109. Lin CC, Ezzelarab M, Hara H et al. Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti-nonGal IgG binding to porcine aortic endothelial cells. J Thromb Haemost 2010; 8: 2001-2010
110. Kaczmarek E, Koziak K, Sevigny J et al. Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 1996; 271: 33116-33122
111. Dwyer KM, Robson SC, Nandurkar HH et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 2004; 113: 1440-1446
112. Crikis S, Lu B, Murray-Segal LM et al. Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Am J Transplant 2010; 10: 2586-2595
113. Huttinger ZM, Milks MW, Nickoli MS et al. Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice. Am J Pathol 2012; 181: 322-333
114. Cai M, Huttinger ZM, He H et al. Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury. J Mol Cell Cardiol 2011; 51: 927-935
115. Wheeler DG, Joseph ME, Mahamud SD et al. Transgenic swine: Expression of human CD39 protects against myocardial injury. J Mol Cell Cardiol 2012; 52: 958-961
116. Le Bas-Bernardet S, Tillou X, Poirier N et al. Xenotransplantation of galactosyl-Transferase knockout, CD55, CD59, CD39, and fucosyltransferase transgenic pig kidneys into baboons. Transplant Proc 2011; 43: 3426-3430
117. Ollinger R, Pratschke J. Role of heme oxygenase-1 in transplantation. Transpl Int 2010; 23: 1071-1081
118. Yeom HJ, Koo OJ, Yang J et al. Generation and characterization of human heme oxygenase-1 transgenic pigs. PLoS One 2012; 7: E46646
119. Petersen B, Ramackers W, Lucas-Hahn A et al. Transgenic expression of human heme oxygenase-1 in pigs confers resistance against xenograft rejection during ex vivo perfusion of porcine kidneys. Xenotransplantation 2011; 18: 355-368
120. Oropeza M, Petersen B, Carnwath JW et al. Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli. Xenotransplantation 2009; 16: 522-534
121. Cho B, Koo OJ, Hwang JI et al. Generation of soluble human tumor necrosis factor-Alpha receptor 1-Fc transgenic pig. Transplantation 2011; 92: 139-147
122. Weiss EH, Lilienfeld BG, Muller S et al. HLA-E/human beta2-microglobulin transgenic pigs: Protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Transplantation 2009; 87: 35-43
123. Wang C, Wang H, Ide K et al. Human CD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPalpha capable of binding to human CD47. Cell Transplant 2011; 20: 1915-1920
124. Kemter E, Lieke T, Kessler B et al. Human TNF-related apoptosis-inducing ligand-expressing dendritic cells from transgenic pigs attenuate human xenogeneic T cell responses. Xenotransplantation 2012; 19: 40-51
125. Cooper DK, Ayares D. The immense potential of xenotransplantation in surgery. Int J Surg 2011; 9: 122-129
126. Martin C, Plat M, Nerriere-Daguin V et al. Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation. Transgenic Res 2005; 14: 373-384
127. Klymiuk N, van Buerck L, Bahr A et al. Xenografted islet cell clusters from INSLEA29Y transgenic pigs rescue diabetes and prevent immune rejection in humanized mice. Diabetes 2012; 61: 1527-1532
128. Phelps CJ, Ball SF, Vaught TD et al. Production and characterization of transgenic pigs expressing porcine CTLA4-Ig. Xenotransplantation 2009; 16: 477-485
129. Nishimura H, Scalea J, Wang Z et al. First experience with the use of a recombinant CD3 immunotoxin as induction therapy in pig-To-primate xenotransplantation: The effect of T-cell depletion on outcome. Transplantation 2011; 92: 641-647
130. McGregor CG, Davies WR, Oi K et al. Cardiac xenotransplantation: Recent preclinical progress with 3-month median survival. J Thorac Cardiovasc Surg 2005; 130: 844-851
131. Mohiuddin MM, Corcoran PC, Singh AK et al. B-cell depletion extends the survival of GTKO.hCD46Tg pig heart xenografts in baboons for up to 8 months. Am J Transplant 2012; 12: 763-771
132. Van Der Windt DJ, Smetanka C, Macedo C et al. Investigation of lymphocyte depletion and repopulation using alemtuzumab (Campath-1H) in cynomolgus monkeys. Am J Transplant 2010; 10: 773-783
133. Kuwaki K, Tseng YL, Dor FJ et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: Initial experience. Nat Med 2005; 11: 29-31
134. Kawai T, Andrews D, Colvin RB et al. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000; 6: 114
135. Knosalla C, Gollackner B, Cooper DK. Anti-CD154 monoclonal antibody and thromboembolism revisted. Transplantation 2002; 74: 416-417
136. Ezzelarab MB, Ekser B, Echeverri G et al. Costimulation blockade in pig artery patch xenotransplantation-A simple model to monitor the adaptive immune response in nonhuman primates. Xenotransplantation 2012; 19: 221-232
137. Thompson P, Cardona K, Russell M et al. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant 2011; 11: 947-957
138. Li Q, Deng SB, Xia S et al. Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: A clinical study. Med Clin (Barc) 2012; 140: 532-536
139. Ezzelarab M, Welchons D, Torres C et al. Atorvastatin down-regulates the primate cellular response to porcine aortic endothelial cells in vitro. Transplantation 2008; 86: 733-737
140. Kuwaki K, Knosalla C, Dor FJ et al. Suppression of natural and elicited antibodies in pig-To-baboon heart transplantation using a human antihuman CD154 mAb-based regimen. Am J Transplant 2004; 4: 363-372
141. Tseng YL, Kuwaki K, Dor FJ et al. alpha1,3-Galactosyltransferase geneknockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 2005; 80: 1493-1500
142. Cozzi E, Simioni P, Boldrin M et al. Effects of long-Term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts. Transplantation 2005; 80: 1501-1510
143. Simioni P, Boldrin M, Gavasso S et al. Effects of long-Term administration of recombinant human protein C in xenografted primates. Transplantation 2011; 91: 161-168
144. Schmelzle M, Cowan PJ, Robson SC. Which anti-platelet therapies might be beneficial in xenotransplantation? Xenotransplantation 2011; 18: 79-87
145. Kawai T, Cosimi AB, Spitzer TR et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353-361
146. Tseng YL, Dor FJ, Kuwaki K et al. Bone marrow transplantation from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Xenotransplantation 2004; 11: 361-370
147. Yang YG. CD47 in xenograft rejection and tolerance induction. Xenotransplantation 2010; 17: 267-273
148. Fu Y, Yi S, Wu J et al. In vitro suppression of xenoimmune-mediated macrophage activation by human CD4CD25 regulatory T cells. Transplantation 2008; 86: 865-874
149. Porter CM, Horvath-Arcidiacono JA, Singh AK et al. Characterization and expansion of baboon CD4CD25 Treg cells for potential use in a non-human primate xenotransplantation model. Xenotransplantation 2007; 14: 298-308
150. Wu J, Yi S, Ouyang L et al. In vitro expanded human CD4CD25 regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses. Transplantation 2008; 85: 1841-1848
151. Sun L, Yi S, O'Connell PJ. Foxp3 regulates human natural CD4CD25 regulatory T-cell-mediated suppression of xenogeneic response. Xenotransplantation 2010; 17: 121-130
152. Veriter S, Gianello P, Igarashi Y et al. Improvement of subcutaneous bioartificial pancreas vascularization and function by co-encapsulation of pig islets and mesenchymal stem cells in primates. Cell Transplant 2013; (e-pub ahead of print
153. Muller YD, Golshayan D, Ehirchiou D et al. T regulatory cells in xenotransplantation. Xenotransplantation 2009; 16: 121-128
154. Muller YD, Ehirchiou D, Golshayan D et al. Potential of T-regulatory cells to protect xenografts. Curr Opin Organ Transplant 2012; 17: 155-161
155. Li J, Ezzelarab MB, Cooper DK. Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. Xenotransplantation 2012; 19: 273-285
156. Ezzelarab M, Ezzelarab C, Wilhite T et al. Genetically-modified pig mesenchymal stromal cells: Xenoantigenicity and effect on human T-cell xenoresponses. Xenotransplantation 2011; 18: 183-195
157. Kumar G, Hara H, Long C et al. Adipose-derived mesenchymal stromal cells from genetically modified pigs: Immunogenicity and immune modulatory properties. Cytotherapy 2012; 14: 494-504
158. Onions D, Cooper DK, Alexander TJ et al. An approach to the control of disease transmission in pig-To-human xenotransplantation. Xenotransplantation 2000; 7: 143-155
159. First WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials: Changsha, China, 19-21 November 2008. The Changsha Communique. Xenotransplantation 2009; 16: 61-63
160. Fishman JA, Scobie L, Takeuchi Y. Xenotransplantation-Associated infectious risk: A WHO consultation. Xenotransplantation 2012; 19: 72-81
161. Millard AL, Mueller NJ. Can human viruses infect porcine xenografts? Xenotransplantation 2010; 17: 6-10
162. Wong BS, Yamada K, Okumi M et al. Allosensitization does not increase the risk of xenoreactivity to alpha1,3-galactosyltransferase geneknockout miniature swine in patients on transplantation waiting lists. Transplantation 2006; 82: 314-319
163. Baertschiger RM, Dor FJ, Prabharasuth D et al. Absence of humoral and cellular alloreactivity in baboons sensitized to pig antigens. Xenotransplantation 2004; 11: 27-32